DK3294904T3 - Fremgangsmåder til vurdering af et mesenkymalt stamcellepræparats renhed - Google Patents

Fremgangsmåder til vurdering af et mesenkymalt stamcellepræparats renhed Download PDF

Info

Publication number
DK3294904T3
DK3294904T3 DK16723062.2T DK16723062T DK3294904T3 DK 3294904 T3 DK3294904 T3 DK 3294904T3 DK 16723062 T DK16723062 T DK 16723062T DK 3294904 T3 DK3294904 T3 DK 3294904T3
Authority
DK
Denmark
Prior art keywords
purity
procedures
evaluation
stem cell
cell preparation
Prior art date
Application number
DK16723062.2T
Other languages
English (en)
Inventor
Denis Dufrane
Original Assignee
Univ Catholique Louvain
Cliniques Univ Saint Luc
Novadip Biosciences Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Catholique Louvain, Cliniques Univ Saint Luc, Novadip Biosciences Sa filed Critical Univ Catholique Louvain
Application granted granted Critical
Publication of DK3294904T3 publication Critical patent/DK3294904T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
DK16723062.2T 2015-05-08 2016-05-09 Fremgangsmåder til vurdering af et mesenkymalt stamcellepræparats renhed DK3294904T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562158875P 2015-05-08 2015-05-08
EP15179417.9A EP3091084A1 (en) 2015-05-08 2015-07-31 Methods for assessing the purity of a mesenchymal stem cells preparation
PCT/EP2016/060351 WO2016180788A1 (en) 2015-05-08 2016-05-09 Methods for assesing the purity of a mesenchymal stem cells preparation

Publications (1)

Publication Number Publication Date
DK3294904T3 true DK3294904T3 (da) 2021-10-11

Family

ID=53776427

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16723062.2T DK3294904T3 (da) 2015-05-08 2016-05-09 Fremgangsmåder til vurdering af et mesenkymalt stamcellepræparats renhed

Country Status (17)

Country Link
US (2) US11203785B2 (da)
EP (2) EP3091084A1 (da)
JP (2) JP6727291B2 (da)
KR (1) KR20180002760A (da)
CN (1) CN107709575B (da)
AU (1) AU2016259736B2 (da)
BR (1) BR112017024011A2 (da)
CA (1) CA2985268A1 (da)
DK (1) DK3294904T3 (da)
ES (1) ES2892487T3 (da)
HK (1) HK1251620A1 (da)
IL (1) IL255500B (da)
MX (1) MX2017014247A (da)
PT (1) PT3294904T (da)
RU (1) RU2738969C2 (da)
WO (1) WO2016180788A1 (da)
ZA (1) ZA201707477B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2019066044A1 (ja) * 2017-09-29 2020-12-10 ファーマバイオ株式会社 標準化発現量を利用した再生医療製品等の品質管理の手法
PL241520B1 (pl) * 2020-03-27 2022-10-17 Polski Bank Komorek Macierzystych Spolka Akcyjna Zastosowanie panelu genów do określania potencjału teratogennego komórek mezenchymalnych i pochodzenia perinatalnego
CN112159794B (zh) * 2020-09-17 2022-07-15 中国人民解放军空军军医大学 骨相关间充质干细胞cd166+亚群的制备及应用
KR20230128452A (ko) * 2020-10-26 2023-09-05 하다지트 메디칼 리서치 써비시즈 앤드 디벨롭먼트 리미티드 중간엽 줄기 세포 및 이의 배양
WO2023052820A1 (en) * 2021-09-30 2023-04-06 Polski Bank Komórek Macierzystych S.A. Expression analysis of a specific gene pool to determine whether the population of adipose tissue-derived mesenchymal cells (at-msc) selected for clinical application can undergo a transformation into neoplastic cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010049139A1 (en) 2000-03-23 2001-12-06 Eric Lagasse Hepatic regeneration from hematopoietic stem cells
ES2325715B1 (es) * 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
JP5416895B2 (ja) * 2007-10-23 2014-02-12 学校法人慶應義塾 単球由来多能性細胞(momc)の効率的な作製法
ES2351916B8 (es) * 2009-07-30 2012-07-09 Centro Nacional De Investigaciones Cardiovasculares (Cnic) Metodo de identificacion de celulas madre mesenquimales senescentes
EP2613776B1 (en) 2010-09-01 2020-07-29 Thomas Jefferson University Composition and method for muscle repair and regeneration
HUE039236T2 (hu) * 2011-07-06 2018-12-28 Cell Therapy Ltd Mezodermális eredetû progenitorsejtek
KR101751355B1 (ko) * 2011-08-24 2017-07-04 (주)아모레퍼시픽 인간 피부 진피 유래 성체 줄기세포
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
KR20140114415A (ko) * 2012-01-13 2014-09-26 제넨테크, 인크. Vegf 길항제로의 치료를 위한 환자를 확인하기 위한 생물학적 마커
JP6198199B2 (ja) * 2013-03-12 2017-09-20 美智代 津留 平行線維性結合組織の製造方法
WO2014144607A1 (en) 2013-03-15 2014-09-18 Turner Designs Hydrocarbon Instruments, Inc. Multi-axis optical measurement of fluid streams with sonic cleaning and homogenization
JP5889856B2 (ja) * 2013-10-15 2016-03-22 佛教慈濟醫療財團法人 生体外でヒト間葉系幹細胞を増殖させる方法、およびそれに用いる補助剤、ならびに、生体外でヒト間葉系幹細胞の成長因子を取り出す方法およびその成長因子の用途

Also Published As

Publication number Publication date
MX2017014247A (es) 2018-06-28
AU2016259736B2 (en) 2022-06-16
CN107709575A (zh) 2018-02-16
PT3294904T (pt) 2021-10-14
AU2016259736A1 (en) 2017-11-30
RU2738969C2 (ru) 2020-12-21
JP6967122B2 (ja) 2021-11-17
KR20180002760A (ko) 2018-01-08
RU2017139097A3 (da) 2019-08-30
CA2985268A1 (en) 2016-11-17
IL255500A (en) 2018-01-31
HK1251620A1 (zh) 2019-02-01
JP2020173265A (ja) 2020-10-22
ES2892487T3 (es) 2022-02-04
WO2016180788A1 (en) 2016-11-17
US20180135124A1 (en) 2018-05-17
US11203785B2 (en) 2021-12-21
US20220064729A1 (en) 2022-03-03
RU2017139097A (ru) 2019-06-10
ZA201707477B (en) 2020-05-27
EP3294904B1 (en) 2021-08-18
JP2018522251A (ja) 2018-08-09
JP6727291B2 (ja) 2020-07-22
CN107709575B (zh) 2022-11-15
BR112017024011A2 (pt) 2018-07-17
IL255500B (en) 2021-04-29
EP3091084A1 (en) 2016-11-09
EP3294904A1 (en) 2018-03-21

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3050896T3 (da) Fremgangsmåde til fremstilling af en polypeptid-heteromultimer
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3372584T3 (da) Fremgangsmåde til fremstillingen af en diarylthiohydantoin-forbindelse
DK3294720T3 (da) Fremgangsmåde til fremstilling af terpinolenepoxid
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3152176T5 (da) Fremgangsmåde til fremstillingen af en cementforbindelse
DK3481838T3 (da) Nye fremgangsmåder til fremstillingen af oligonukleotider
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK2953904T3 (da) Fremgangsmåde til kontrolleret fremstilling af et biocid
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3689380T3 (da) Bløde kapsler af calcifediol
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3277915T3 (da) Fremgangsmåde til nedlukning af en brøn
DK3166611T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer
DK3294904T3 (da) Fremgangsmåder til vurdering af et mesenkymalt stamcellepræparats renhed
DK3365436T3 (da) Fremgangsmåder til fremstilling af en primær celleprøve
DK3262023T3 (da) Fremgangsmåde til fremstillingen af diener
DK3116854T3 (da) Ny fremgangsmåde til fremstilling af prostaglandiner med høj renhed
DK3328574T3 (da) Fremgangsmåde til fremstilling af en monotektisk legering
DK3250523T3 (da) Fremgangsmåde til fremstillingen af en silikasmeltemasse
DK3286209T3 (da) Fremgangsmåde til fremstilling af gonadotrophin
DK3295941T3 (da) Fremgangsmåde til fremstilling af form a af grapiprant